We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · June 20, 2021

Long-Term Efficacy and Safety of Erenumab



Additional Info

Long-Term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study
Neurology 2021 Jun 01;96(22)e2724-e2735, PJ Goadsby, U Reuter, M Lanteri-Minet, G Paiva da Silva Lima, P Hours-Zesiger, C Fernandes, S Wen, N Tenenbaum, A Kataria, MD Ferrari, J Klatt

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading